269 related articles for article (PubMed ID: 26518423)
1. Stratification of ALS patients' survival: a population-based study.
Marin B; Couratier P; Arcuti S; Copetti M; Fontana A; Nicol M; Raymondeau M; Logroscino G; Preux PM
J Neurol; 2016 Jan; 263(1):100-11. PubMed ID: 26518423
[TBL] [Abstract][Full Text] [Related]
2. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis.
Dandaba M; Couratier P; Labrunie A; Nicol M; Hamidou B; Raymondeau M; Logroscino G; Preux PM; Marin B;
Neuroepidemiology; 2017; 49(1-2):64-73. PubMed ID: 28873374
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with amyotrophic lateral sclerosis in a population-based registry.
Millul A; Beghi E; Logroscino G; Micheli A; Vitelli E; Zardi A
Neuroepidemiology; 2005; 25(3):114-9. PubMed ID: 15956808
[TBL] [Abstract][Full Text] [Related]
6. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register).
Marin B; Hamidou B; Couratier P; Nicol M; Delzor A; Raymondeau M; Druet-Cabanac M; Lautrette G; Boumediene F; Preux PM;
Eur J Neurol; 2014 Oct; 21(10):1292-300, e78-9. PubMed ID: 24909935
[TBL] [Abstract][Full Text] [Related]
7. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
9. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
[TBL] [Abstract][Full Text] [Related]
10. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
11. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
Lunetta C; Lizio A; Melazzini MG; Maestri E; Sansone VA
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):93-100. PubMed ID: 26470943
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register).
Luna J; Defressigne O; Erazo D; Lautrette G; Raymondeau-Moustafa M; Preux PM; Boumediene F; Couratier P
Rev Neurol (Paris); 2022 Nov; 178(9):914-923. PubMed ID: 36163089
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis.
Marin B; Arcuti S; Jesus P; Logroscino G; Copetti M; Fontana A; Nicol M; Raymondeau M; Desport JC; Preux PM; Couratier P;
Neurodegener Dis; 2016; 16(3-4):225-34. PubMed ID: 26866503
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
[TBL] [Abstract][Full Text] [Related]
16. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study.
Kjældgaard AL; Pilely K; Olsen KS; Jessen AH; Lauritsen AØ; Pedersen SW; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Elmo EG; Møller AT; Bonefeld L; Berg M; Garred P; Møller K
BMC Neurol; 2021 Apr; 21(1):164. PubMed ID: 33865343
[TBL] [Abstract][Full Text] [Related]
17. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
18. Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis.
Tortelli R; Arcuti S; Copetti M; Barone R; Zecca C; Capozzo R; Barulli MR; Simone IL; Logroscino G
Acta Neurol Scand; 2018 Jul; 138(1):55-61. PubMed ID: 29527672
[TBL] [Abstract][Full Text] [Related]
19. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
20. Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression.
Zhang YJ; Fan DS
Chin Med J (Engl); 2016 Jan; 129(1):28-32. PubMed ID: 26712429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
